Cas:23363-35-1 (5S,5aR,8aR,9R)-9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8, 8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl β-D-g lucopyranoside manufacturer & supplier

Chemical Name:(5S,5aR,8aR,9R)-9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8, 8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl β-D-g lucopyranoside

CAS.NO:23363-35-1

Synonyms:4′-O-demethylpodophyllotoxin;4′-demethyl-epipodophyllotoxin;4′-demethylpodophyllotoxine;4-Demethyl-Podophyllotoxin

Molecular Formula:C₂₇H₃₀O₁₃

Molecular Weight:562.51900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:808.2ºC at 760mmHg

Density:1.62g/cm3

Index of Refraction:1.688

PSA:182.83000

Exact Mass:562.16900

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4′-O-demethylpodophyllotoxin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Demethyl-Podophyllotoxin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4′-demethylpodophyllotoxine Use and application,4′-demethylpodophyllotoxine technical grade,usp/ep/jp grade.

Related News: Airlines operating in the United States will be required to ask all passengers booked on flights from outside the US if they��ve been to mainland China in last 14 days. (5S,5aR,8aR,9R)-9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8, 8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl β-D-g lucopyranoside manufacturer The company reported that it was cooperating with the Justice Department probe and that an outside law firm was also “investigating these allegations thoroughly.” (5S,5aR,8aR,9R)-9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8, 8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl β-D-g lucopyranoside supplier Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. (5S,5aR,8aR,9R)-9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8, 8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl β-D-g lucopyranoside vendor The company reported that it was cooperating with the Justice Department probe and that an outside law firm was also “investigating these allegations thoroughly.” (5S,5aR,8aR,9R)-9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8, 8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl β-D-g lucopyranoside factory Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule.